Skin Health Institute has a proud history of collaborating with international and local pharmaceutical companies as well as National Collaborative Groups on a variety of clinical trials and research projects. The Skin Health Institute is also signatory to an agreement as collaborator with Probity Medical Research, a Canadian-based clinical trials consortium presided over by Dr Kim Papp, who is a world authority on designing, implementing and conducting clinical trials.

Successful treatments approved for use in Australia that were tested by our Clinical Trials Department include:

Psoriasis Atopic Dermatitis Skin Cancer/ Actinic Keratosis Hidradenitis Suppurativa Rosacea/Chronic Spontaneous Urticaria
Humira Elidel Aldara Humira Soolantra (Rosacea)
Remicade Staquis Erivedge Xolair (CSU)
Cosentyx Desowen Picato
Taltz Dupixent PDT Metvix & Daylight PDT
Tremfya Upadacitinib
Enbrel (also for Psoriatic Arthritis)
Scroll to Top